Clinical Trial Update: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from Duke University on preventing progression from intraductal papillary mucinous neoplasm to pancreatic cancer; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraductal Papillary Mucinous Neoplasm of the Pancreas
• Pancreatic Adenocarcinoma

Snippet

Sponsor: Duke University | Conditions: IPMN, IPMN, Pancreatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING